Skip to main content

S Saxena

First name:
S
Last name:
Saxena
Chakraborty, A. ., Mishra, A. ., Soni, A. ., Regina, T. ., Mohil, R. ., Bhatnagar, D. ., … Saxena, S. . Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detection and Prevention, 32(5-6), 386-94. Retrieved from https://linkinghub.elsevier.com/retrieve/pii/S1877-7821(09)00035-6 (Original work published 2009)
Saxena, S. ., Pant, A. ., Khanna, V. ., Agarwal, A. ., Singh, K. ., Kumar, D. ., & Singh, V. . (1969). Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease. Ocular Immunology and Inflammation, 17(3), 201-6. https://doi.org/10.1080/09273940902731015 (Original work published 1969)
Tomlinson, M. ., Rudan, I. ., Saxena, S. ., Swartz, L. ., Tsai, A. ., & . (2009). Setting priorities for global mental health research. Bulletin of the World Health Organization, 87(6), 438-46. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862009000600012&lng=en&nrm=iso&tlng=en
Amato, R. ., Shingler, W. ., Goonewardena, M. ., de Belin, J. ., Naylor, S. ., Jac, J. ., … Harrop, R. . (2009). Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial. Journal of Immunotherapy (Hagerstown, Md. : 1997), 32(7), 765-72. https://doi.org/10.1097/CJI.0b013e3181ace876
Ayers, C. ., Saxena, S. ., Golshan, S. ., & Wetherell, J. . (2010). Age at onset and clinical features of late life compulsive hoarding. International Journal of Geriatric Psychiatry, 25(2), 142-9. https://doi.org/10.1002/gps.2310
Saxena, S. ., Jais, M. ., Dutta, R. ., & Dutta, A. . (2009). Serological immunity to diphtheria and tetanus in healthy adults in Delhi, India. Tropical Doctor, 39(3), 160-3. https://doi.org/10.1258/td.2008.080274
Laxman, T. ., Puttervu, S. ., Mishra, A. ., Verma, S. ., Singh, S. ., Sashidhara, K. ., … Bhatta, R. . (2019). Evaluation of interconversion pharmacokinetics of 16α-hydroxycleroda-3,13(14)Z-dien-15,16-olide - a novel HMG-CoA reductase inhibitor and its acid metabolite using multi-compartmental pharmacokinetic model in mice. Xenobiotica; The Fate of Foreign Compounds in Biological Systems, 49(4), 474-483. https://doi.org/10.1080/00498254.2018.1451933
Pathak, N. ., Ghosh, P. ., Saxena, S. ., Dutta, D. ., Yadav, A. ., Bhattacharyya, D. ., … Kadam, R. . (2018). Exploring Defect-Induced Emission in ZnAl<sub>2</sub>O<sub>4</sub>: An Exceptional Color-Tunable Phosphor Material with Diverse Lifetimes. Inorganic Chemistry, 57(7), 3963-3982. https://doi.org/10.1021/acs.inorgchem.8b00172 (Original work published 2018)
Wani, S. ., Sahu, A. ., Saxena, S. ., Rajak, K. ., Saminathan, M. ., Sahoo, A. ., … Gandham, R. . (2018). Expression kinetics of ISG15, IRF3, IFNγ, IL10, IL2 and IL4 genes vis-a-vis virus shedding, tissue tropism and antibody dynamics in PPRV vaccinated, challenged, infected sheep and goats. Microbial Pathogenesis, 117, 206-218. https://doi.org/10.1016/j.micpath.2018.02.027
Saxena, S. ., Hayashi, Y. ., Wu, L. ., Awaji, M. ., Atri, P. ., Varney, M. ., … Singh, R. . (2018). Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget, 9(5), 5931-5943. https://doi.org/10.18632/oncotarget.23644 (Original work published 2018)